Posts Archive

IFM - (Intergroupe Francophone du Myélome) Time Frame: October 1990 and May 1993 IFM trial: Conventional chemo or high-dose therapy and auto bone marrow transplantation - NEJM 1996 A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma N Engl J Med 1996 Conventional chemotherapy or high-dose therapy and autologous bone marrow transplantation. (Intergroupe Francophone du Myélome) Click here for details

Time Frame: December 1997 and June 1998 Phase 2: Antitumor Activity of Thalidomide in Refractory Multiple Myeloma - NEJM 1999 Antitumor Activity of Thalidomide in Refractory Multiple Myeloma Seema Singhal, M.D., Jayesh Mehta, M.D., Raman Desikan, M.D., Dan Ayers, M.S., Paula Roberson, Ph.D., Paul Eddlemon, B.S., Nikhil Munshi, M.D., Elias Anaissie, M.D., Carla Wilson, M.D., Ph.D., Madhav Dhodapkar, M.D., Jerome Zeldis, M.D., David Siegel, M.D., Ph.D., John Crowley, Ph.D., and

Time Frame: August 1990 and August 1995 Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood; 1999 B Barlogie 1, S Jagannath, K R Desikan, S Mattox, D Vesole, D Siegel, G Tricot, N Munshi, A Fassas, S Singhal, J Mehta, E Anaissie, D Dhodapkar, S Naucke, J Cromer, J Sawyer, J Epstein, D Spoon, D Ayers, B Cheson, J Crowley Remission induction utilized non-cross-resistant regimens (vincristine-doxorubicin-dexamethasone [VAD], high-dose cyclophosphamid

Time Frame: October 1996 and October 2000 Results of autologous stem cell transplant in multiple myeloma patients with renal failure British Journal of Haematology 20 December 2001 Results of autologous stem cell transplant in multiple myeloma patients with renal failure Ashraf Badros,Bart Barlogie,Eric Siegel,Jennifer Roberts,Candi Langmaid,Maurizio Zangari,Raman Desikan,Mary Jo Shaver,Athanasios Fassas,Scott McConnell,Firas Muwalla,Yousri Barri,Elias Anaissie,Nikhil Munshi,